• Mon, December 12, 2022
Joseph Thome Initiated (XENE) at Buy on, Dec 12th, 2022
Joseph Thome of Cowen & Co., Initiated "Xenon Pharmaceuticals Inc." (XENE) at Buy on, Dec 12th, 2022.
Joseph has made no other calls on XENE in the last 4 months.
There are 5 other peers that have a rating on XENE. Out of the 5 peers that are also analyzing XENE, 0 agree with Joseph's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Joseph
- Mohit Bansal of "Wells Fargo" Initiated at Buy and Held Target at $50 on, Monday, November 28th, 2022
- Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Decreased Target to $49 on, Friday, November 11th, 2022
- Danielle Brill of "Raymond James" Initiated at Buy and Held Target at $52 on, Wednesday, October 19th, 2022
- Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $49 on, Tuesday, October 11th, 2022
- Jason Gerberry of "B of A Securities" Initiated at Strong Buy on, Monday, August 29th, 2022
